MicroRNAs (miRNAs) are differentially expressed after ischemic stroke and by blocking or enhancing these miRNAs, we can control their expression and effects. Through the study of an in vitro cell line based system, miRNA inhibitors are being studied as a potential treatment for ischemic stroke, with specific emphasis on the efficacy of PNA and gamma PNA inhibitors in the HEK 293 cell line.